• THE THOMPSON LAB

    Department of Neurosurgery

    WashU Medicine

  • Our Vision

    The Thompson Lab investigates the molecular mechanisms of and treatment for leptomeningeal dissemination of pediatric brain tumors, focusing on the Abelson family of nonreceptor tyrosine kinases (ABL1 and ABL 2). The lab also develops immunotherapies to treat malignant pediatric brain tumors, focusing on peptide vaccines that target CMV antigens. Dr. Eric Thompson is also the Principal Investigator of multiple investigator initiated clinical trials of immunotherapy to treat malignant pediatric brain tumors.

  • The Team

    broken image

    Eric M. Thompson, MD

    Dr. Eric Thompson is a Professor of Neurosurgery, Chief of the Division of Pediatric Neurosurgery, and Co-Directory of the Pediatric Brain Tumor Program at Washington University. Dr. Thompson received his Bachelor of Science degree from Duke University and his MD from the University of Nebraska College of Medicine prior to completing neurosurgery residency and a two year post doctoral fellowship in neuro-oncology at Oregon Health & Science University. He completed his pediatric neurosurgery fellowship at the Hospital for Sick Children in Toronto.

     

    broken image

    Jianyun Lu, PhD

    Dr. Jianyun Lu is a Staff Scientist in the Thompson Lab. Dr. Lu received his Bachelor of Science and Master's of Science in chemistry at Zhongshan University in China. He completed his PhD in chemistry from the University of Georgia in Athens. He has more than eight years experience in cancer research, and his career goal is to discover and devlop innovative therapeutics to cure cancer.

  • Selected Publications

    2024

    broken image

    TULIPs decorate the three-dimensional genome of PFA ependymoma.

    Johnston MJ, Lee JJY, Hu B, Nikolic A, Hasheminasabgorji E, Baguette A, Paik S, Chen H, Kumar S, Chen CCL, Jessa S, Balin P, Fong V, Zwaig M, Michealraj KA, Chen X, Zhang Y, Varadharajan S, Billon P, Juretic N, Daniels C, Rao AN, Giannini C, Thompson EM, Garami M, Hauser P, Pocza T, Ra YS, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska W, Perek-Polnik M, Agnihotri S, Mack S, Ellezam B, Weil A, Rich J, Bourque G, Chan JA, Yong VW, Lupien M, Ragoussis J, Kleinman C, Majewski J, Blanchette M, Jabado N, Taylor MD, Gallo M. Cell.

    broken image

    The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study.

    Barkley A, Butler E, Park C, Friedman A, Landi D, Ashley DM, Bigner D, Bernstock JD, Friedman GK, Johnston JM*, Thompson EM*. Journal of Neurosurgery: Pediatrics. 2024; 33:359-366. Cover article.

    broken image

    Identification of genetic biomarkers to predict response to HSV-1 G207 and polio:rhinovirus immunotherapy.

    Thompson EM, Kang KD, Stevenson K, Zhang H, Gromeier M, Ashley D, Brown M, Friedman GK. ITranslational Oncology. 2024; 40.

    broken image

    ABL1 and ABL2 regulate c-MYC-mediated medulloblastoma leptomeningeal dissemination.

    Jones JK, Zhang H, Lyne AM, Cavalli FMG, Hassen WE, Stevenson K, Kornahrens R, Yang Y, Li S, Dell S, Reitman ZJ, Herndon JE 2nd, Hoj J, Pendergast AM, Thompson EM. Neuro-Oncology Advances. 2023; 5(1). 

    2023

    broken image

    Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial

    broken image

    CD155 is a putative therapeutic target in medulloblastoma

    Li S, McLendon R, Sankey E, Kornaherns R, Lyne AM, Cavalli FMG, McKay Z, Herndon II JE, Remke M, Picard D, Gromeier M, Brown M, Thompson EM. Clinical and Translational Oncology. 2023; 25(3):696-705.

    2022

    broken image

    Failure of human rhombic lip differentiation underlies medulloblastoma formation

    Hendrikse LD, Haldipur P, Saulnier O, Millman J, Sjoboen AH, Erickson A, Ong W, Gordon V, Coudière-Morrison L, Mercier AL, Shokouhian M, Suárez RA, Ly M, Borlase S, Scott DS, Vladoiu MC, Farooq H, Sirbu O, Nakashima T, Nambu S, Funakoshi Y, Bahcheli A, Diaz-Mejia J, Golser J, Bach K, Phuong-Bao T, Skowron P, Wang E, Kumar S, Balin P, Visvanathan A, Lee JJY, Ayoub R, Chen X, Chen X, Mungall KL, Luu B, Bérubé P, Wang YC, Pfister SM, Delattre O, Kim SK, Bourdeaut F, Doz FP, Masliah-Planchon J, Grajkowska WA, Loukides J, Dirks P, Fèvre-Montange M, Jouvet A, French PJ, Kros JM, Zitterbart K, Bailey SD, Eberhart CG, Rao AAN, Giannini C, Olson JM, Garami M, Hauser P, Phillips JJ, Ra YS, de Torres C, Mora J, Li KKW, Ng HK, Poon WS, Pollack IF, López-Aguilar E, Gillespie GY, Van Meter TE, Shofuda T, Vibhakar R, Thompson RC, Cooper MK, Rubin JB, Kumabe T, Jung S, Lach B, Ferrucci V, De Antonellis P, Zollo M, Robinson S, Stearns DS, Van Meir EG, Porrati P, Finocchiaro G, Massimino M, Carlotti CG, Faria CC, Roussel MF, Boop F, Chan JA, Aldinger KA, Razavi F, Silvestri E, McLendon RE, Thompson EM, Ansari M, Garre ML, de León FCP, Aguilar PE, Conti MPPD, Morrissy SA, Cavalli FMG, Wu X, Daniels C, Rich JN, Jones SJM, RA Moore, Marra MA, Huang X, Reimand J, Sorensen PHB, Wechsler-Reya RJ, Weiss WA, Pugh TJ, Garzia L, Kleinman CL, Stein LD, Jabado N, Malkin D, Ayrault O, Golden JA, Ellison DW, Doble B, Ramaswamy V, Werbowetski-Ogilvie TE, Suzuki H, Millen KJ, Taylor MD. Nature. 2022; 609(7929):1021-1028.

    2021

    broken image

     

    Skowron P, Farooq H, Cavalli1 FMG, Morrissy AS, Ly M, Hendrikse LD, Wang EY, Djambazian H, Zhu H, Mungall KL, Trinh QM, Zheng T, Dai S, Stücklin AG, Vladoiu MC, Fong V, Holgado BL, Nor C, Wu X, Abd-Rabbo D, Bérubé P, Wang YC, Luu B, Suárez RA, Rastan A, Gillmor AH, Lee JJY, Zhang XY, Daniels C, Dirks P, Malkin D, Bouffet E, Tabori U, Loukides J, Doz FP, Bourdeaut F, Delattre OO, Masliah-Planchon J, Ayrault O, Kim SK, Meyronet D, Grajkowska WA, Carlotti CG, de Torres C, Mora J, Eberhart CG, Van Meir EG, Kumabe T, French PJ, Kros JM, Jabado N, Lach B, Pollack IF, Hamilton RL, Nageswara Rao AA, Giannini C, Olson JM, László B, Klekner A, Zitterbart K, Phillips JJ, Thompson RC, Cooper MK, Rubin JB, Liau LM, Garami M, Hauser P, Wai Li KK, Ng H, Poon WS, Gillespie GY, Chan JA, Jung S, McLendon RE, Thompson EM, Zagzag D, Vibhakar R, Ra RS, Garre ML, Schüller U, Shofuda T, Faria CC, López-Aguilar E, Zadeh G, Hui CC, Ramaswamy V, Bailey SD, Jones SJM, Mungal AJ, Moore RA, Calarco J, Stein L, Bader GD, Reimand J, Ragoussis J, Weiss WA, Marra MA, Suzuki H, Taylor MD. Nature Communications, 2021; 12(1):1749.

    2020

    broken image

     

     

    Tsvankin V, Hashizume R, Katagi H, Herndon JE, Lascola C, Venkatraman TN, Picard D, Burrus B, Becher OJ, Thompson EM. Neurosurgery, 2020; 86(5):742-751. PMID: 31225627.

    2019

    broken image

     

    Childhood cerebellar tumours mirror conserved fetal transcriptional programs

     

    Vladoiu MC, El-Hamamy I, Donovan LK, Farooq H, Holgado BL, Sundaravadanam Y, Ramaswamy V, Hendrikse LD, Kumar S, Mack SC, Lee JJY, Fong V, Juraschka K, Przelicki D, Michealraj A, Skowron P, Luu B, Suzuki H, Morrissy AS, Cavalli FMG, Garzia L, Daniels C, Wu X, Qazi MA, Singh SK, Chan JA, Marra MA, Malkin D, Dirks P, Heisler L, Pugh T, Ng K, Notta F, Thompson EM, Kleinman CL, Joyner AL, Jabado N, Stein L, Taylor MD. Nature. 2019;572(7767):67-73. PMID: 31043743.

  • Contact Us

    Students and residents interested in working in the Thompson Lab are encouraged to reach out to Dr. Eric Thompson directly at t.eric@wustl.edu. 

  • Giving

    If you are interested in supporting the Thompson Lab and its work toward finding a cure for pediatric brain tumors, please contact: 

    Laura Caveny
    Senior Director of Advancement, Patient and Friends Program
    WashU Medicine Advancement
    314-935-0482

    caveny@wustl.edu